Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

REGENERON PHARMACEUTICALS

(REGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about REGENERON PHARMACEUTICALS
11/26MarketScreener's World Press Review - November 26, 2021
11/26Merck's COVID-19 pill significantly less effective in new analysis
RE
11/23Nykode Therapeutics in Vaccine Deal With Regeneron Worth Up to $925 Million
DJ
11/23Nykode, Regeneron to Team Up On Cancer, Infectious Disease Vaccines
MT
11/23Nykode Therapeutics Enters into Collaboration Agreement with Regeneron to Develop Innov..
CI
11/23Vaccibody AS announced that it expects to receive NOK 178.305538 million in funding fro..
CI
11/22Regeneron Extends Research Collaboration With Decibel Therapeutics; Decibel Shares Rise..
MT
11/22Decibel Therapeutics, Inc. Announces Extension of Research Term Under Strategic Collabo..
CI
11/19BioNTech's Skin Cancer Vaccine Candidate Wins US FDA's Fast Track Status
MT
11/18WALL STREET STOCK EXCHANGE : Trading is the new online gambling
11/18INSIDER SELL : Regeneron Pharmaceuticals
MT
11/16Roche walks away from Atea partnership to develop COVID-19 pill
RE
11/16Regeneron Announces Investor Conference Presentations
PR
11/15Regeneron antibody cocktail approved by european commission to treat and prevent covid-..
AQ
11/15Regeneron announces $3 billion share repurchase program
AQ
11/15Regeneron Listed on Dow Jones Sustainability World Index for Third Consecutive Year
PR
11/12Regeneron Pharmaceuticals Board Approves $3 Billion Share Buyback Program
MT
11/12Regeneron Announces $3 Billion Share Repurchase Program
PR
11/12Regeneron Pharmaceuticals, Inc. announces an Equity Buyback for $3,000 million worth of..
CI
11/12Regeneron Secures European Commission Approval for Antibody Cocktail to Treat, Prevent ..
MT
11/12European Commission Grants Marketing Authorization For Roche's COVID-19 Antibody Cockta..
MT
11/12Regeneron Antibody Cocktail Approved by European Commission to Treat and Prevent COVID-..
PR
11/12EC Formally Authorises COVID-19 Drugs From Regeneron-Roche, Celltrion
RE
11/12GSK-Vir COVID-19 antibody works as shot in the arm as well as infusion
RE
11/12Regeneron Pharmaceuticals, Inc. authorizes a Buyback Plan.
CI
11/11EU Drug Regulator Backs COVID-19 Therapy from South Korea's Celltrion
MT
11/11Roche, Regeneron's COVID-19 Antibody Cocktail Gets European Medicines Agency's Recommen..
MT
11/11Regeneron Gets CHMP Backing for Covid-19 Cocktail
DJ
11/11Regeneron Pharmaceuticals Gets Recommendation for EU Approval of COVID-19 Antibody Cock..
MT
11/11European Medicines Agency Recommends Ronapreve, Regkirona Covid-19 Treatments for Appro..
DJ
11/11CHMP Recommends EU Approval of Regeneron Antibody Cocktail to Treat and Prevent COVID-1..
PR
11/11European Medicines Agency's Committee for Medicinal Products for Human Use Recommends A..
CI
11/09Regeneron Pharmaceuticals - NEW PHASE 3 ANALYSES SHOW THAT A SINGLE DOSE OF REGEN-COV (..
AQ
11/09EU Poised To Approve Two COVID-19 Antibody Drugs
MT
11/09Amid spike in cases, EU to shortly approve first COVID antibody drugs - sources
RE
11/09Amid spike in cases, EU to shortly approve first COVID antibody drugs - sources
RE
11/08Health Care Climbs On Sales Expectations -- Health Care Roundup
DJ
11/08Regeneron Study Shows COVID-19 Drug Cocktail Almost 82% Effective in Preventing Infecti..
MT
11/08Regeneron says antiviral COVID-19 cocktail shows protection after 8 months
AQ
11/08Regeneron Says Regen-Cov Antibody Cocktail Reduces Risk of Contracting COVID-19 by 81.6..
MT
11/08Regeneron Pharmaceuticals's COVID-19 Drug Reduces Infection Risk by 82% in Late-Stage S..
MT
11/08Regeneron's antibody drug shows protection against COVID-19 for up to 8 months
RE
11/08Regeneron's antibody therapy shows long-term protection against COVID-19
RE
11/08Regeneron Pharmaceuticals, Inc. Announces New Phase 3 Analyses Shows Single Dose of Reg..
CI
11/05Regeneron Pharmaceuticals Files Shelf Registration Statement For Potential Security Off..
MT
11/05Pfizer COVID-19 pill data slams competitors' shares, shakes up healthcare sector
RE
11/05HC Wainwright Adjusts Price Target on Regeneron Pharmaceuticals to $844 From $842, Main..
MT
11/05UBS Adjusts Price Target on Regeneron Pharmaceuticals to $770 From $763, Maintains Buy ..
MT
11/05Today on Wall Street: All is well
11/05Regeneron presentations at ash highlight expanding clinical research in blood cancers a..
AQ
11/05Benchmark Downgrades Regeneron Pharmaceuticals to Hold from Buy
MT
11/05Morgan Stanley Raises Price Target on Regeneron Pharmaceuticals to $617 From $571, Main..
MT
11/05ANALYST RECOMMENDATIONS : BP, GlaxoSmithKline, Nikola, Papa John's, Qualcomm...
11/04WALL STREET STOCK EXCHANGE : Tapering fears? It’s so 2020ů
11/04Regeneron Corporate Presentation November 2021
PU
11/04Regeneron beats quarterly sales on COVID-19 drug demand
RE
11/04Regeneron Reports Third Quarter 2021 Financial and Operating Results - Form 8-K
PU
11/04Regeneron Pharmaceuticals Earnings Almost Double in Q3 as Sales Jump; Shrinks 2021 R&D ..
MT
11/04REGENERON : Q3 Earnings Snapshot
AQ
11/04Earnings Flash (REGN) REGENERON PHARMACEUTICALS Posts Q3 EPS $15.37, vs. Street Est of ..
MT
11/04Earnings Flash (REGN) REGENERON PHARMACEUTICALS Posts Q3 Revenue $3.45B, vs. Street Est..
MT
10/26SVB Leerink Adjusts Regeneron Pharmaceuticals' Price Target to $798 from $785, Keeps Ou..
MT
10/25ZAI LAB : Says First Patient Treated in China Portion of Global Study of Odronextamab for ..
MT
10/25REGENERON PHARMACEUTICALS : Second dupixent (dupilumab) phase 3 eosinophilic esophagitis t..
AQ
10/25SANOFI : Regeneron's Second Late-Stage Inflammatory Disease Trial Meets Primary Endpoints
MT
10/25SANOFI : Regeneron's Dupixent Improves Swallowing in Late-Stage Study
MT
10/25REGENERON PHARMACEUTICALS : Second Dupixent« (dupilumab) Phase 3 Eosinophilic Esophagitis ..
PR
10/22SANOFI : Regeneron's Dupixent Meets Primary, Key Secondary Endpoints in Phase 3 Trial in P..
MT
10/22REGENERON, SANOFI : Dupixent Hits Main Endpoints in Prurigo Nodularis Trial
DJ
10/22SANOFI : Regeneron's Dupixent Cuts Itch in Late-Stage Skin Disease Study
MT
10/21REGENERON PHARMACEUTICALS : Fda expands approval of dupixent (dupilumab) to include childr..
AQ
10/20SANOFI : Regeneron Win Expanded US FDA Nod for Asthma Drug Dupixent
MT
10/20REGENERON PHARMACEUTICALS : Sanofi Say FDA Has Expanded Approval of Dupixent to Include Ch..
MT
10/20REGENERON PHARMACEUTICALS : FDA Expands Approval of Dupixent« (dupilumab) to Include Child..
PR
10/14REGENERON PHARMACEUTICALS : FDA Accepts Regeneron's 'Regen-Cov" For Priority Review for Tr..
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on REGENERON PHARMACEUTICALS
11/30/21